Preclinical Evaluation of the Cardiotoxicity of Taxane–Anthracycline Combinations Using the Model of Isolated Perfused Rat Heart

This publication has 10 references indexed in Scilit:

• Lack of Increased Cardiac Toxicity with Sequential Doxorubicin and Paclitaxel
  Cancer Investigation, 1998
• Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.
  Journal of Clinical Oncology, 1997
• Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.
  Journal of Clinical Oncology, 1997
• Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
  Annals of Oncology, 1996
• Anthracycline-Induced Cardiotoxicity
  Annals of Internal Medicine, 1996
• Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention
  British Journal of Pharmacology, 1996
• Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice
  British Journal of Cancer, 1996
• Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.
  Journal of Clinical Oncology, 1995
• The influence of pressure overload left ventricular hypertrophy on diastolic properties during hypoxia in isovolumically contracting rat hearts.
  Circulation Research, 1986
• Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography
  Analytical Biochemistry, 1979